tru Independence’s Boston Scientific BSX Stock Holding History

tru Independence’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-28	Closed	-$1	–	342
2020 Q4	$1	Buy	+28	New	+$1.01K	﹤0.01%	664

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

tru Independence's BSX Position: Q1 2021 in Review

tru Independence sold out of Boston Scientific (BSX) in Q1 2021, closing a stake of 28 shares — an estimated $1 sold.

tru Independence first reported a position in BSX in Q4 2020 and held it in 1 quarter. The position peaked at $1 in Q4 2020. 830 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

tru Independence reported no remaining Boston Scientific position as of Q1 2021 after selling out during the quarter.
tru Independence sold 28 Boston Scientific shares in Q1 2021, an estimated $1.
tru Independence first reported a position in Boston Scientific in Q4 2020 and held it in 1 quarter.
tru Independence's Boston Scientific position peaked at $1 in Q4 2020.
830 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on tru Independence's 13F filing for Q1 2021, filed 20 May 2021.